Related Experiment Videos
Hemorrhage and hemorrhagic infections in the brain
1Memorial Magnetic Resonance Center, Long Beach Memorial Medical Center, California.
Abstract:
Hemorrhage in the brain can be accurately staged using a combination of T1- and T2-weighted MR images. The MR appearance depends on the form of hemoglobin present and on whether hemolysis has occurred. The stages of hemorrhage distinguishable by MR imaging are: hyperacute (less than 1 day, intracellular oxyhemoglobin), acute (1-3 day, intracellular methemoglobin), late subacute (7-14 days, extracellular methemoglobin) and chronic (14+ days, hemosiderin rim).
Insights
Brain hemorrhage staging is accurately achieved using T1- and T2-weighted MRI. The imaging appearance evolves with hemoglobin changes and hemolysis, allowing differentiation of hyperacute, acute, subacute, and chronic stages.
Area of Science:
- Radiology
- Neurology
- Medical Imaging
Background:
- Brain hemorrhage diagnosis and staging are critical for patient management.
- Magnetic Resonance (MR) imaging offers detailed visualization of brain tissue.
Purpose of the Study:
- To demonstrate the utility of T1- and T2-weighted MR images for staging intracranial hemorrhages.
- To correlate MR imaging findings with the biochemical composition of blood breakdown products.
Main Methods:
- Utilized a combination of T1- and T2-weighted MR imaging sequences.
- Analyzed MR signal characteristics corresponding to different hemoglobin states and hemolysis.
Main Results:
- Identified distinct MR imaging appearances for hyperacute (<1 day), acute (1-3 days), late subacute (7-14 days), and chronic (14+ days) hemorrhage.
- Correlated these stages with intracellular oxyhemoglobin, intracellular methemoglobin, extracellular methemoglobin, and hemosiderin rim, respectively.
Conclusions:
- T1- and T2-weighted MR imaging provide accurate staging of brain hemorrhages.
- The evolving MR appearance reflects the sequential degradation of hemoglobin within the brain.